The Cigna Group (CI)
Cigna (CI) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Cigna Group (CI) Q2 2026 Earnings Call Transcript
The Cigna Group (CI) Q2 2026 Earnings Call Transcript
Cigna (CI) Q2 Earnings and Revenues Top Estimates
Cigna (CI) came out with quarterly earnings of $7.78 per share, beating the Zacks Consensus Estimate of $7.58 per share. This compares to earnings of $7.2 per share a year ago.
As New CEO Takes Charge, Cigna Reports $1.7 Billion Quarterly Profit
The Cigna Group Thursday reported second quarter net income of nearly $1.7 billion despite continued elevated medical costs dogging the entire health insurance industry.
Cigna Group Lifts Outlook, Logs Higher Profit on Growth Across Businesses
Cigna Group lifted its outlook and reported a higher profit in the second quarter, driven by growth in both its healthcare and pharmacy-benefit businesses.
Cigna raises annual profit forecast on strength in health services unit
Cigna on Thursday raised its annual profit forecast, after beating quarterly earnings estimates on growth in its pharmacy and specialty drug businesses.
Will Declining Medical Customers Affect Cigna's Q2 Earnings?
CI's Q2 earnings are likely to face pressure from fewer insured medical customers and a higher MCR despite expected revenue growth.
Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Seeking Clues to Cigna (CI) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cigna (CI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.
Why Cigna (CI) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Cigna (CI) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward
Cigna's Evernorth launched AI-powered Pharmacy Forward to speed up specialty prescriptions, cut delays and boost efficiency with a $100M investment.
